We are aware that some of our shareholders have from time to time received unsolicited telephone calls and/or correspondence from individuals or companies claiming to be authorized by BioNTech in relation to investment matters. The caller is often from an overseas broker or an online investment platform, contacts the shareholder out of the blue, is extremely persuasive and may offer unsolicited advice, offer to buy shares at a discount or offer free company reports.
These scams have been highlighted by the US Securities and Exchange Commission (SEC) and the German Federal Financial Supervisory Authority (BaFin) as being on the increase, and the SEC and BaFin recommend that investors be on high alert and conduct thorough research prior to making any investment decisions. The SEC and BaFin provide useful tips for investors to help recognize and avoid frauds.
If you suspect that you have been contacted by fraudsters, you should check whether the particular individual or person is properly licensed by conducting a search on the SEC’s Investor.gov database (in the US) or in BaFin’s Database of Companies (Unternehmensdatenbank) (in Germany).
You can also check whether a telephone call or correspondence you have received or an investment opportunity on a website is legitimate by contacting our Investor Relations team in the US or in Germany.